HSE and pharma firm Vertex urged by Cystic Fibrosis Ireland to resolve pricing dispute
National Centre For Pharmacoeconomics
Cost of deal is three times annual budget usually in place for new drugs in Republic
Apporval means HSE will reimburse patients for cost of cannabis-based treatment for the first time
Debate about economic restrictions versus Covid suffering has been shirked in Ireland
Up to 1% of Co Donegal population has been estimated to have the hereditary condition
Patient’s insurer refuses to cover €40,000 cost of treatment as drug has not been approved for particular cancer
When a cure is found for Friedreich’s ataxia, will I face the long campaign to access treatment funding endured by other people with rare diseases?
HSE has agreed to reimburse Kuvan for up to 20pc of patients with rare metabolic disorder
Biogen, maker of drug to treat spinal muscular atrophy, drops price of medicine
Most Read
You may also like...
Crosswords & puzzles to keep you challenged and entertained
Start The Search For Your Next Job
Audio versions of the best journalism from The Irish Times